1. Home
  2. HTBK vs ESPR Comparison

HTBK vs ESPR Comparison

Compare HTBK & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HTBK

Heritage Commerce Corp

HOLD

Current Price

$11.96

Market Cap

667.4M

Sector

Finance

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.84

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTBK
ESPR
Founded
1997
2008
Country
United States
United States
Employees
N/A
304
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
667.4M
898.5M
IPO Year
1998
2013

Fundamental Metrics

Financial Performance
Metric
HTBK
ESPR
Price
$11.96
$3.84
Analyst Decision
Strong Buy
Buy
Analyst Count
4
7
Target Price
$11.88
$6.86
AVG Volume (30 Days)
361.3K
6.7M
Earning Date
01-22-2026
11-06-2025
Dividend Yield
4.51%
N/A
EPS Growth
N/A
N/A
EPS
0.70
N/A
Revenue
$187,676,000.00
$303,802,000.00
Revenue This Year
$13.16
$25.45
Revenue Next Year
$7.61
N/A
P/E Ratio
$16.48
N/A
Revenue Growth
10.94
2.83
52 Week Low
$8.09
$0.69
52 Week High
$11.71
$4.03

Technical Indicators

Market Signals
Indicator
HTBK
ESPR
Relative Strength Index (RSI) 76.48 63.33
Support Level $11.06 $3.68
Resistance Level $11.48 $4.00
Average True Range (ATR) 0.26 0.24
MACD 0.08 0.02
Stochastic Oscillator 96.53 83.06

Price Performance

Historical Comparison
HTBK
ESPR

About HTBK Heritage Commerce Corp

Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. A majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: